CRIS

CURIS INC Files SEC form 10-Q, Quarterly Report

moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

Curis Reports First Quarter 2014 Financial Results

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology-focused drug development company developing novel drug candidates for the treatment of human cancers, today reported its financial results for the first quarter … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

3:42 am Curis and Debiopharm Group report preclinical data for Debio 0932; demonstrated anti-tumor activity and synergy with various SOC agents

moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

4:04 pm Curis and Debiopharm Group(TM) report preclinical data for debio 0932 at AACR annual meeting 2014; demonstrated synergy between Debio 0932 and various standard of care (<a href=/q?s=soc.v name=soc.

moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

Narrower-than-Expected Loss at Curis

moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

Curis to Present at the Cowen and Company 34th Annual Health Care Conference

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced that the Company will present at the Cowen and … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

Curis Management Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Daniel R. Passeri Yes, thanks, Ali. Good morning, everyone. I’ll first begin with Erivedge, which is being developed and commercialized globally by Genentech and Roche under our existing collaboration…. moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]